Compromised antigen presentation ranks among the top mechanisms that render cancers non-immunogenic (non-responsive to immune ...

But sometimes, cell ... look for cancer cells. Doctors rely on various types of imaging technologies for viewing cancers inside the body. These techniques include MRI, which creates pictures ...

S, Principal Investigator at A*STAR SRL are co-authors of the study. While the current study focuses on basal cell carcinoma (BCC), researchers believe the technology could also be adapted to ...

Breast cancer is becoming increasingly treatable, but in some cases the disease can resurface even decades after a patient ...

Signet cell cancer is a rare type of cancer that mostly starts in the glandular cells. It is also called signet ring cell cancer. Nearly 57 out of 100 (57%) of all signet cell cancers start in the ...

researchers delivered 7.7 to 22.3 times more of the drug inside cancer cells, making the treatment up to 23 times more potent than before, according to the study published April 17 in Cell.

that could significantly improve the diagnosis and treatment of basal cell carcinoma (BCC), the most common form of skin cancer worldwide. This advanced technique uses photoacoustic imaging (PAI), ...

To overcome this hurdle, the researchers designed a multifunctional nanoplatform capable of reshaping the tumor microenvironment and enhancing the body's natural immune defense against cancer.

Sanofi is handing back a phase 2-stage natural killer (NK) cell engager and canceling another cancer trial as the Big Pharma refocuses its relationship with Innate Pharma from oncology to ...